M Baum
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Genetics top 0.5%
- Estrogen and related hormone effects
- BRCA gene mutations in cancer
Papers in ⓘ
-
- Breast Cancer Treatment Studies 8
- Oncology 11
- Cancer Treatment and Pharmacology 5
- Global Cancer Incidence and Screening 4
- Co-authors
- Aman U. Budzar (1 shared paper)Joanna Houghton (1 shared paper)Tarek Sahmoud (1 shared paper)JF Forbes (1 shared paper)J Cuzick (1 shared paper)J.G.M. Klijn (1 shared paper)John Forbes (2 shared papers)A. Buzdar (1 shared paper)
- Journals
- The Breast (3 papers)Journal of the Royal Society of Medicine (3 papers)The Lancet (3 papers)Clinical Radiology (2 papers)European Journal of Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
M Baum
33 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 1.6k
- Genetics 2.4k
- Oncology 2.0k
- Family Practice 90
- Orthopedics and Sports Medicine 230
Countries citing papers authored by M Baum
This map shows the geographic impact of M Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Baum more than expected).
Fields of papers citing papers by M Baum
This network shows the impact of papers produced by M Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Baum. The network helps show where M Baum may publish in the future.
Co-authors
The 25 scholars most cited alongside M Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer Hit paper breakdown → | 2005 | 1715 |
| 2 | Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Hit paper breakdown → | 2002 | 1461 |
| 3 | Anastozole (A) is superior to tamoxifen (T) in treatment of postmenopausal (PM) women with early breast cancer (EBC) - First results of the ATAC (Arimidex, tamoxifen, alone or in combination) trial (on behalf of the ATAC Trialists' Group) | 2002 | 191 |
| 4 | 1993 | 44 | |
| 5 | For and against | 2000 | 34 |
| 6 | 1991 | 23 | |
| 7 | 1991 | 22 | |
| 8 | Mass breast screening: is there a hidden cost? | 2003 | 19 |
| 9 | 1997 | 16 | |
| 10 | 1976 | 16 | |
| 11 | 1995 | 11 | |
| 12 | Cosmetic outcome after targeted intraoperative radiotherapy (TARGIT) for early breast cancer | 2003 | 8 |
| 13 | 1976 | 8 | |
| 14 | 1997 | 7 | |
| 15 | Spleen size in women with breast cancer. | 1979 | 6 |
| 16 | Should lymphadenectomy be discarded? I. Immunological considerations. | 1973 | 5 |
| 17 | The management of advanced breast cancer. | 1980 | 4 |
| 18 | 2019 | 4 | |
| 19 | Commentaries on Research in Breast Disease, vol 2 | 1983 | 3 |
| 20 | Pure antioestrogens in breast cancer - experimental and clinical observations | 1994 | 3 |
About M Baum
M Baum is a scholar working on Cancer Research, Oncology, Computer Graphics and Computer-Aided Design, Radiation and Genetics, having authored 34 papers that have together received 3.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Cancer Treatment and Pharmacology (5 papers), Estrogen and related hormone effects (5 papers), Global Cancer Incidence and Screening (4 papers), Abdominal Trauma and Injuries (2 papers), Health, Medicine and Society (2 papers), Aging, Elder Care, and Social Issues (2 papers) and Hermeneutics and Narrative Identity (2 papers). The work is most often cited by research in Cancer Research (1.6k citations), Genetics (2.4k citations), Oncology (2.0k citations), Family Practice (90 citations) and Orthopedics and Sports Medicine (230 citations). M Baum has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Aman U. Budzar, Joanna Houghton, Tarek Sahmoud, JF Forbes, J Cuzick, J.G.M. Klijn, John Forbes, A. Buzdar, J. Houghton and Gershon Y. Locker. Their work appears in journals such as The Breast, Journal of the Royal Society of Medicine, The Lancet, Clinical Radiology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.